TIL · XBRL financial data

Instil Bio financial statements, every fiscal year

The same tables from 5 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal years (TIL's year ends in late December)

In thousands of dollarsDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Revenue from contracts with customers0————
Research and development107,251141,05639,604——
General and administrative48,30962,23547,55344,21027,221
Total operating expenses155,560226,458159,16973,54178,581
Operating income (loss)(155,560)(226,458)(159,169)(73,541)(78,581)
Interest expense01,8835,2098,9925,829
Income tax expense (benefit)39(2,073)0—0
Net income (loss)(156,794)(223,177)(156,087)(74,135)(71,372)
Earnings per share, basic‡ USD per share(29.60)(34.40)(24.00)(11.39)(10.70)
Earnings per share, diluted‡ USD per share(29.60)(34.40)(24.00)(11.39)(10.70)
Weighted average shares, basic‡ thousands of shares5,3006,4766,5046,5106,668
Weighted average shares, diluted‡ thousands of shares5,3006,4766,5046,5106,668
  • ‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (December 2023); filings made before it reported them unadjusted.

Balance sheet

CSV

Fiscal years (TIL's year ends in late December)

In thousands of dollarsDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Cash and cash equivalents37,59043,7169,1958,8056,638
Marketable securities416,509217,204141,161——
Prepaid and other current assets9,9218,4588,9029,3253,038
Total current assets464,020269,378160,759124,470191,429
Property and equipment, net121,999196,880138,684129,406126
Right-of-use asset012,4572,387934238
Goodwill5,7220———
Total assets609,983482,128325,630263,567203,523
Accounts payable5,5682,3591,212659779
Total current liabilities41,35832,78810,5597,8964,843
Lease liability, non-current05,1712,8771,0170
Total liabilities54,784118,52399,80194,13189,657
Accumulated deficit(201,717)(424,894)(580,981)(655,116)(726,488)
Total stockholders' equity555,199363,605225,829169,436113,866
Total liabilities and equity609,983482,128325,630263,567203,523
Common shares outstanding (cover page)‡ thousands of shares6,4576,5046,5046,5266,782
  • ‡ Per-share figures and share counts are adjusted for the 1-for-20 stock split (December 2023); filings made before it reported them unadjusted.

Cash flows

CSV

Fiscal years (TIL's year ends in late December)

In thousands of dollarsDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Net income (loss)(156,794)(223,177)(156,087)(74,135)(71,372)
Stock-based compensation26,19730,44118,16617,2578,693
Depreciation and amortization2,7525,9874,7563,610534
Net cash from operating activities(122,138)(180,164)(82,029)(55,696)(36,619)
Purchases of property and equipment57,83184,58920,6630—
Net cash from investing activities(474,396)114,54141,12853,97425,476
Proceeds from issuing common stock———06,611
Net cash from financing activities393,16471,8868,0821,7557,292

Compare with peers

The peer list for this company is being put together from its industry's latest filings. Reload the page in a minute to see it.

Not investment advice. Not affiliated with the U.S. SEC.